We additional analyzed the prognostic relevance of IGF2BP1 in breast cancer by applying enrichment analysis of DEGs, and our data revealed the involvement of pathways such as glucuronidation, cytochrome P450 (CYP) enzyme-related drug metabolism, cornification, and keratinization. This evidence concerns the gene IGF2BP1 and breast carcinoma.